Poll: Ophthalmologists Eager to Use Corneal Crosslinking

A Medscape poll finds US ophthalmologists eager to access the newly FDA-approved keratoconus treatment that the majority of the world has enjoyed for some time.
Medscape Medical News

Full Story →